Results 291 to 300 of about 463,247 (329)
Some of the next articles are maybe not open access.
Current Opinion in Gastroenterology, 1992
Intestinal metaplasia in Barrett's esophagus is a major risk factor for esophageal adenocarcinoma, a tumor whose incidence rate has more than tripled in the United States over the past 2 decades. Studies have identified a number of molecular abnormalities that may be involved in the progression from dysplasia to cancer in Barrett's esophagus, including
openaire +8 more sources
Intestinal metaplasia in Barrett's esophagus is a major risk factor for esophageal adenocarcinoma, a tumor whose incidence rate has more than tripled in the United States over the past 2 decades. Studies have identified a number of molecular abnormalities that may be involved in the progression from dysplasia to cancer in Barrett's esophagus, including
openaire +8 more sources
Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.
Human Pathology, 2001Morphologic assessment of dysplasia in Barrett esophagus, despite limitations, remains the basis of treatment. We rigorously tested modified 1988 criteria, assessing intraobserver and interobserver reproducibility.
E. Montgomery +13 more
semanticscholar +1 more source
Archives of Surgery, 1977
Barrett esophagus is the term describing the presence of an abnormal columnar epithelium in a portion of the esophagus. We have treated 19 patients within the past three years, representing almost 20% of all our esophageal experience; This one pathologic entity has presented as several different clinical pictures: benign stricture, peptic ulceration of
L R, Radigan +3 more
openaire +2 more sources
Barrett esophagus is the term describing the presence of an abnormal columnar epithelium in a portion of the esophagus. We have treated 19 patients within the past three years, representing almost 20% of all our esophageal experience; This one pathologic entity has presented as several different clinical pictures: benign stricture, peptic ulceration of
L R, Radigan +3 more
openaire +2 more sources
Current Opinion in Gastroenterology, 2004
Strides have been made in the past year to identify means of decreasing mortality from esophageal adenocarcinoma. This requires a thorough understanding of the risk factor for its development, Barrett esophagus. This article summarizes the most up-to-date and important advancements involving the epidemiology, screening, pathogenesis, surveillance, and ...
John A, Bonino, Prateek, Sharma
openaire +2 more sources
Strides have been made in the past year to identify means of decreasing mortality from esophageal adenocarcinoma. This requires a thorough understanding of the risk factor for its development, Barrett esophagus. This article summarizes the most up-to-date and important advancements involving the epidemiology, screening, pathogenesis, surveillance, and ...
John A, Bonino, Prateek, Sharma
openaire +2 more sources
Barrett’s esophagus and Barrett’s carcinoma
Current Oncology Reports, 2003The alarming rise in the incidence of esophageal adenocarcinomas in the Western world has focused interest on so-called Barrett's esophagus. Barrett's esophagus is characterized by specialized intestinal epithelium replacing the normal squamous epithelium in the distal esophagus and is considered a consequence of long-lasting and severe ...
Hubert J. Stein +2 more
openaire +3 more sources
Biomarkers in Barrett Esophagus
Mayo Clinic Proceedings, 2001Barrett esophagus is a premalignant condition that may progress to adenocarcinoma. The risk of developing cancer has been estimated to be approximately 1 in 250 patient-years of observation; however, there appear to be subsets of patients at much higher risk. Risk stratification has previously been determined by histological identification of dysplasia.
Brian J. Reid +2 more
openaire +3 more sources
Gastroenterology, 2017
BACKGROUND & AIMS A system is needed to determine the risk of patients with Barrett's esophagus for progression to high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC).
S. Parasa +18 more
semanticscholar +1 more source
BACKGROUND & AIMS A system is needed to determine the risk of patients with Barrett's esophagus for progression to high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC).
S. Parasa +18 more
semanticscholar +1 more source
Gastroenterology, 2016
BACKGROUND & AIMS Although several classification systems have been proposed for characterization of Barrett's esophagus (BE) surface patterns based on narrow-band imaging (NBI), none have been widely accepted. The Barrett's International NBI Group (BING)
Prateek Sharma +13 more
semanticscholar +1 more source
BACKGROUND & AIMS Although several classification systems have been proposed for characterization of Barrett's esophagus (BE) surface patterns based on narrow-band imaging (NBI), none have been widely accepted. The Barrett's International NBI Group (BING)
Prateek Sharma +13 more
semanticscholar +1 more source
Computer-aided detection of early neoplastic lesions in Barrett’s esophagus
Endoscopy, 2016Background and study aims: Early neoplasia in Barrett’s esophagus is difficult to detect and often overlooked during Barrett’s surveillance. An automatic detection system could be beneficial, by assisting endoscopists with detection of early neoplastic ...
F. van der Sommen +8 more
semanticscholar +1 more source
Gastritis in Barrett's esophagus
World Journal of Surgery, 1995AbstractDuodenogastric reflux has been implicated in the pathogenesis of complicated Barrett's esophagus and gastric ulceration. A group of 123 Barrett's patients were followed for a mean of 41 months; 9 (7%) developed gastric ulceration (GU). Of the Barrett's patients treated by antireflux surgery, 14% developed GU.
Cedric G. Bremner, Rodney J. Mason
openaire +3 more sources